Intravenous immunoglobulins in the treatment of post-COVID: A case-control study
J Intern Med
.
2023 May;293(5):656-658.
doi: 10.1111/joim.13592.
Epub 2022 Dec 2.
Authors
Maximilian Hogeweg
1
,
Adrian Doevelaar
1
,
Sonja Rieckmann
1
,
Felix Seibert
1
,
David Scholten
2
,
Monika Segelmacher
2
,
Ulrik Stervbo
1
,
Nina Babel
1
,
Timm H Westhoff
1
Affiliations
1
Medical Department, University Hospital Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany.
2
Medical Department, Marien Hospital Witten, Witten, Germany.
PMID:
36414570
DOI:
10.1111/joim.13592
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19*
Case-Control Studies
Humans
Immunoglobulins
Immunoglobulins, Intravenous* / therapeutic use
Substances
Immunoglobulins, Intravenous
Immunoglobulins